載入...
1409. Evaluation of Alternative Piperacillin–tazobactam Dosing Strategies Against ESBL-Producing Enterobacteriaceae Using a Hollowfiber Infection Model
BACKGROUND: Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae exhibit variable response to treatment with piperacillin–tazobactam. Current clinical practice with piperacillin–tazobactam involves dosing the components simultaneously at a fixed ratio of 8:1 piperacillin to tazobactam....
Na minha lista:
| 發表在: | Open Forum Infect Dis |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6254524/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1240 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|